COPD

Looking into the eye of patients with chronic obstructive pulmonary disease
READ ARTICLE
Impaired Hemorheology in Exacerbations of COPD
READ ARTICLE
The Epidemiology of Vascular Dysfunction Relating to Chronic Obstructive Pulmonary Disease and Emphysema
READ ARTICLE
Oxygen dependence of endothelium-dependent vasodilation: importance in chronic obstructive pulmonary disease
READ ARTICLE

Break Free the Bonds of COPD

 

D’OXYVA® enhances the rest and digest (parasympathetic) nerve activation process in the part of the brain that is responsible for all subconscious functions (ANS) and microcirculation processes to invigorate your lung capacity.

Join our newsletter today and get the first dibs to new articles and exclusive discounts!

invigorate your lung capacity

enhance Essential Nerve Activities and microcirculation processes

According to a study published in Archives of Medical Science, patients with COPD, decreased systemic oxygen levels lead to endothelial dysfunction, underlining the relevance of cardiopulmonary interaction and the potential importance of pulmonary treatment in secondary prevention of vascular disease.

D’OXYVA® (deoxyhemoglobin vasodilator) is the pioneering non-invasive biotech solution created by the health science experts at Circularity — validated to signigicantly increase microcirculation and oxygentaion in a single painless, convenient, and affordable solution.

Those living with chronic obstructive pulmonary disease (COPD), emphysema, asthma, and chronic bronchitis disorders suffer from two distinct defects in critical lung functioning.
The inability of delicate air sacs to absorb oxygen -- resulting in an imbalance of oxygen to carbon dioxide (CO₂) -- and a loss of overall lung elasticity -- resulting in the inability to properly expel CO₂.
Those patients who use D’OXYVA daily notice a marked increase in microcirculation and oxygen absorption at the cellular level, resulting in an easier breathing condition and enhanced recovery after physical activity exertion.
After just a single 5-minute administration, users in various clinical trials recorded dramatic improvements of two or three times the baseline readings in macro- and microcirculatory blood flow for over 4 hours post-application.
For more D’OXYVA product and procedure information, exciting client testimonials, and D’OXYVA discounts and special promotions, join our social media channels or join our newsletter!
Previous
Next

Finally Breathe Easier with D’OXYVA!

        BUY D’OXYVA

versatile, non-toxic

D’OXYVA for Advanced Neonatal Care

As part of a carefully planned application protocol for newborn infants in neonatal care and neonatal ICU facilities, D’OXYVA’s versatile, over-the-skin, non-toxic CO₂ and soothing vapor delivery system has the potential to dramatically improve microcirculation and the comprehensive function of developing lungs.

Finally Breathe Easier with D’OXYVA!

        BUY D’OXYVA

act now before it's too late

What Makes D’OXYVA Truly Different

How To Start?

Follow the Standard Application Guide — Or, Get Your Personalized Plan

Recent Related Blog Posts

Impaired Hemorheology in Exacerbations of COPD

Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation. Cardiovascular-related comorbidities are established to contribute to morbidity and mortality especially during exacerbations. The aim of the current study

Read More »

Reduce unwanted doctor visits, recommended and ranked top by experts!